Wolverine Trading
NBIX icon

Wolverine Trading’s Neurocrine Biosciences NBIX Stock Holding History

Wolverine Trading’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,915
Closed -$539K – 5189
2024
Q2 		$539K Sell
3,915
-2,945
-43% -$404K ﹤0.01% 2771
2024
Q1 		$946K Buy
+6,860
New +$937K ﹤0.01% 2251
2022
Q2 		– Sell
-4,768
Closed -$440K – 5306
2022
Q1 		$441K Buy
+4,768
New +$404K ﹤0.01% 3399
2021
Q4 		– Sell
-4,537
Closed -$417K – 6492
2021
Q3 		$428K Buy
4,537
+1,518
+50% +$143K ﹤0.01% 4161
2021
Q2 		$293K Buy
3,019
+461
+18% +$44.2K ﹤0.01% 4454
2021
Q1 		$241K Sell
2,558
-3,287
-56% -$345K ﹤0.01% 4785
2020
Q4 		$558K Sell
5,845
-567
-9% -$54.8K ﹤0.01% 3040
2020
Q3 		$626K Buy
+6,412
New +$742K ﹤0.01% 2565
2020
Q2 		– Sell
-8,352
Closed -$923K – 4998
2020
Q1 		$765K Buy
+8,352
New +$817K ﹤0.01% 2196
2019
Q1 		– Sell
-4,660
Closed -$389K – 5032
2018
Q4 		$319K Sell
4,660
-6,940
-60% -$665K ﹤0.01% 3121
2018
Q3 		$1.43M Buy
+11,600
New +$1.32M ﹤0.01% 1981
2017
Q1 		– Sell
-17,389
Closed -$673K – 4742
2016
Q4 		$673K Buy
+17,389
New +$787K ﹤0.01% 2299

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's NBIX Position: Q3 2024 in Review

Wolverine Trading sold out of Neurocrine Biosciences (NBIX) in Q3 2024, closing a stake of 3,915 shares — an estimated $539K sold.

Wolverine Trading first reported a position in NBIX in Q4 2016 and held it in 12 quarters. The position peaked at $1.43M in Q3 2018. 574 funds tracked by Wall St. Rank hold NBIX as of Q3 2024.

  • Wolverine Trading reported no remaining Neurocrine Biosciences position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 3,915 Neurocrine Biosciences shares in Q3 2024, an estimated $539K.
  • Wolverine Trading first reported a position in Neurocrine Biosciences in Q4 2016 and held it in 12 quarters.
  • Wolverine Trading's Neurocrine Biosciences position peaked at $1.43M in Q3 2018.
  • 574 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.